Irene Perlich SEC EDGAR Filings (CIK 0001989954)

SEC EDGAR filings, ownership reports, and insider transactions for Irene Perlich.

Business address
C/O Ngm Biopharmaceuticals, Inc., 333 Oyster Point Boulevard, South San Francisco, CA, 94080
Get insider transactions for this reporting owner
Irene Perlich has filed 4 SEC EDGAR filings since 18 Sep 2023

Latest Filings

Recent SEC filings for Irene Perlich including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 4 08 Apr 2024 05 Apr 2024 001-38853
4 Open 4 document View SEC filing for 4 18 Jan 2024 16 Jan 2024 001-38853
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 08 Nov 2023 06 Nov 2023 001-38853
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 18 Sep 2023 15 Sep 2023 001-38853

About this filer

Irene Perlich files with the SEC under CIK 0001989954. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages